Business
Top brokers name 3 ASX shares to buy next week 17 January 2021
Last week saw a number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.
Here’s why brokers think investors ought to buy them next week:
According to a note out of Credit Suisse, its analysts have retained their outperform rating and $4.30 price target on this healthcare company’s shares. The broker believes that Healius is well-placed to benefit from increased demand for COVID testing. Combined with a reduction in costs and smart investments, it is expecting strong earnings growth in the near term. The Healius share price ended the week at $3.88.
Analysts at Morgan Stanley have initiated coverage on this investigative analytics and intelligence software provider’s…
-
Business21 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News21 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business17 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News19 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses